Editorial

Treatment of Late Stage Non-small Cell Lung Cancer: We Have More Work to Do

Authors: Coty Ho, MD

Abstract

The successful treatment of non-small cell lung cancer (NSCLC), like most solid tumors, still relies on complete surgical resection. However, a meaningful disease-free interval with surgery alone has been typically restricted to early stages I and II. Over the years, we have made slight improvements in the overall survival and quality of life for patients with more advanced stages, although these improvements have been relegated to patients with a “decent” performance status who can tolerate more intense combined modality therapy or chemotherapy alone.

This content is limited to qualifying members.

Existing members, please login first.

If you have an existing account please login now to access this article or view your purchase options.

Purchase only this article ($15)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Vokes EE, Green MR. Clinical studies in non-small cell lung cancer: the CALG experience. Cancer Invest 1998;16:72–79.
 
2. Winton T, Livingston R, Johnson D, et al. Vinorelbine plus cisplatin vs. observation in resected non-small cell lung cancer. N Engl J Med 2005;352:2589–2597.
 
3. Pister K. Adjuvant Chemotherapy for non-small-cell lung cancer: the smoke clears. N Engl J Med2005;352:2640–2642.
 
4. Dillman RO, Herndon J, Seagren SL, et al. Improved survival in stage III non-small cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial. J Natl Cancer Inst1966;88:1210–1215.
 
5. Kiernan PD, Sheridan MJ, Lamberti J. Late stage (III and IV) non-small cell cancer of the lung: results of surgical resection at Inova Fairfax Hospital. South Med J 2005;98:1088–1094.
 
6. Schuchert MJ, Luketich JD. Solitary sites of metastatic disease in non-small cell lung cancer. Curr Treat Options Oncol 2003;4:65–79.
 
7. Downey RJ. Non-small cell lung cancer with a solitary hematogenous metastasis. Thorac Surg Clin2004;14:265–269.
 
8. Okamoto T, Maruyama R, Shoji F, et al. Long-term survivors in stage IV non-small cell lung cancer.Lung Cancer 2005;47:85–91.
 
9. Lin NU, Bellon JR, Winer EP. CNS metastases in breast cancer. J Clin Oncol 2004;22:3608–3617.